ZZW-115
| 中文名称 | ZZW-115 |
|---|---|
| 中文同义词 | N,N-二甲基-2-(4-(3-(2-(三氟甲基)-10H-吩噻嗪-10-基)丙基)哌嗪-1-基)乙胺 |
| 英文名称 | 1-Piperazineethanamine, N,N-dimethyl-4-[3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]- |
| 英文同义词 | 1-Piperazineethanamine, N,N-dimethyl-4-[3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-;ZZW-115;ZZW115,ZZW 115;N,N-Dimethyl-2-(4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethan-1-amine |
| CAS号 | 801991-87-7 |
| 分子式 | C24H31F3N4S |
| 分子量 | 464.59 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 801991-87-7.mol |
| 结构式 |  |
ZZW-115 性质
| 储存条件 | Store at -20°C |
|---|
ZZW-115 (0.1-33 μM; 72 hours) is efficient in killing cancer cells, with an IC
50
in the range of 0.84 μM (ANOR) to 4.93 μM (HN14).
ZZW-115 (0-100 μM; 24-72 hours) is efficient to kill these tumor cells with an IC
50
in the range of 0.42 μM (Hep2G cells) to 7.75 μM (SaOS-2 cells).
ZZW-115 induces pancreatic cell death by necrosis and apoptosis. ZZW-115 treatment induces a decrease in ATP production and induces a ROS overproduction.
LDH release is significantly higher in ZZW-115-treated cells (MiaPaCa-2, 02-063, LIPC, Foie8b, and HN14 cells) than in control cells in a concentration-dependent manner. Similarly, caspase 3/7 activity is also greater in ZZW-115-treated cells. These experiments demonstrated that ZZW-115 exerted both pronecrotic and proapoptotic effects.
Cell Viability Assay
| Cell Line: | ANOR cells, MiaPaCa-2, 02-063, 01008, LIPC, 02136, HN01,01046, AOIPC, Foie8b, HN14 cells |
| Concentration: | 0.1- 33 μM |
| Incubation Time: | 72 hours |
| Result: | Was efficient in killing cancer cells, with an IC 50 in the range of 0.84 μM (ANOR) to 4.93 μM (HN14). |
Cell Proliferation Assay
| Cell Line: | U87, A375, U2OS, SaOS-2, HT29, SK-CO-1, LS174T, H1299 and H358, HepG2, PC3, THP-1, Daudi, Jurkat and MDA-MB-231 cells |
| Concentration: | 0-100 μM |
| Incubation Time: | 24 or 72 hours |
| Result: | Was efficient to kill these tumor cells with an IC 50 in the range of 0.42 μM (Hep2G cells) to 7.75 μM (SaOS-2 cells). |
ZZW-115 (0.5-5 mg/kg; injection; daily for 30 days) inhibits the growth of pancreatic xenografted tumors.
ZZW-115 (5 mg/kg for 30 days; immunocompetent C57BL/6 mice were orthotopically implanted with Panc02 cells) treatment shows the tumor size is almost unmeasurable in some cases.
| Animal Model: | NMRI-Foxn1nu/Foxn1nu mice (nude mice) xenografted with MiaPaCa-2 cells |
| Dosage: | 5, 2.5, 1.0, or 0.5 mg/kg |
| Administration: | Injection, daily for 30 days |
| Result: | When the mice were injected with 5 mg/kg ZZW-115, the tumors stopped growing a few days after treatment and their size decreased progressively, almost disappearing at the end of the treatment. |
安全信息
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2025/12/22 | HY-111838 | ZZW-115 | 801991-87-7 | 1 mg | 2000元 |
| 2025/12/22 | HY-111838 | ZZW-115 | 801991-87-7 | 5mg | 4700元 |